204 related items for PubMed ID: 31605028
1. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis.
An JN, Hyeon JS, Jung Y, Choi YW, Kim JH, Yang SH, Oh S, Kwon S, Lee SH, Cho JH, Park SH, Ha H, Kim DK, Lee JP, Hwang GS.
Sci Rep; 2019 Oct 11; 9(1):14707. PubMed ID: 31605028
[Abstract] [Full Text] [Related]
2. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V, López D, Boixadera E, Ibernón M, Espinal A, Bonet J, Romero R.
BMC Nephrol; 2017 Feb 03; 18(1):49. PubMed ID: 28158993
[Abstract] [Full Text] [Related]
3. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
Pediatr Nephrol; 2014 Aug 03; 29(8):1363-71. PubMed ID: 24263531
[Abstract] [Full Text] [Related]
4. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
Ramezani A, Devaney JM, Cohen S, Wing MR, Scott R, Knoblach S, Singhal R, Howard L, Kopp JB, Raj DS.
Eur J Clin Invest; 2015 Apr 03; 45(4):394-404. PubMed ID: 25682967
[Abstract] [Full Text] [Related]
5. [The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis].
Li YH, Huang HC, Liu G, Zhang YK.
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr 03; 36(2):135-8. PubMed ID: 15100729
[Abstract] [Full Text] [Related]
6. Urinary fibrinogen and renal tubulointerstitial fibrinogen deposition: Discriminating between primary FSGS and minimal change disease.
Wang Y, Zheng C, Xu F, Liu Z.
Biochem Biophys Res Commun; 2016 Sep 23; 478(3):1147-52. PubMed ID: 27539323
[Abstract] [Full Text] [Related]
7. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.
Kurasawa S, Kato S, Ozeki T, Akiyama S, Ishimoto T, Mizuno M, Tsuboi N, Kato N, Kosugi T, Maruyama S, J-MARINE collaborators.
Clin Exp Nephrol; 2024 May 23; 28(5):431-439. PubMed ID: 38267800
[Abstract] [Full Text] [Related]
8. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM, da Silva CA, Monteiro MLGDR, Araújo LS, Rocha LP, Reis MBDR, Ramalho FS, Corrêa RRM, Silva MV, Reis MA, Machado JR.
PLoS One; 2019 May 23; 14(6):e0217569. PubMed ID: 31188898
[Abstract] [Full Text] [Related]
9. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
Pediatr Nephrol; 2017 Oct 23; 32(10):1897-1905. PubMed ID: 28540445
[Abstract] [Full Text] [Related]
10. Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
Li F, Zheng C, Zhong Y, Zeng C, Xu F, Yin R, Jiang Q, Zhou M, Liu Z.
Clin J Am Soc Nephrol; 2014 Nov 07; 9(11):1903-11. PubMed ID: 25318750
[Abstract] [Full Text] [Related]
11. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.
Kidney Int; 2010 Aug 07; 78(3):296-302. PubMed ID: 20485332
[Abstract] [Full Text] [Related]
12. Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children.
Huang Z, Zhang Y, Zhou J, Zhang Y.
Biomed Res Int; 2017 Aug 07; 2017():7298160. PubMed ID: 28246603
[Abstract] [Full Text] [Related]
13. Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients.
Navarro-Muñoz M, Ibernon M, Pérez V, Ara J, Espinal A, López D, Bonet J, Romero R.
Nephrol Dial Transplant; 2011 Dec 07; 26(12):3914-23. PubMed ID: 21414970
[Abstract] [Full Text] [Related]
14. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.
Spinale JM, Mariani LH, Kapoor S, Zhang J, Weyant R, Song PX, Wong HN, Troost JP, Gadegbeku CA, Gipson DS, Kretzler M, Nihalani D, Holzman LB, Nephrotic Syndrome Study Network.
Kidney Int; 2015 Mar 07; 87(3):564-74. PubMed ID: 25354239
[Abstract] [Full Text] [Related]
15. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA, Monteiro MLGDR, Araújo LS, Urzedo MG, Rocha LB, Dos Reis MA, Machado JR.
PLoS One; 2020 Mar 07; 15(11):e0241745. PubMed ID: 33147279
[Abstract] [Full Text] [Related]
16. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
Wagrowska-Danilewicz M, Danilewicz M.
Nefrologia; 2007 Mar 07; 27(6):710-5. PubMed ID: 18336100
[Abstract] [Full Text] [Related]
17. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
Mishra OP, Kumar R, Narayan G, Srivastava P, Abhinay A, Prasad R, Singh A, Batra VV.
Pediatr Nephrol; 2017 Aug 07; 32(8):1355-1361. PubMed ID: 28210837
[Abstract] [Full Text] [Related]
18. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.
Meijers B, Maas RJ, Sprangers B, Claes K, Poesen R, Bammens B, Naesens M, Deegens JK, Dietrich R, Storr M, Wetzels JF, Evenepoel P, Kuypers D.
Kidney Int; 2014 Mar 07; 85(3):636-40. PubMed ID: 24402090
[Abstract] [Full Text] [Related]
19. Serum-soluble urokinase receptor concentration in primary FSGS.
Maas RJH, Wetzels JFM, Deegens JKJ.
Kidney Int; 2012 May 07; 81(10):1043-1044. PubMed ID: 22543906
[No Abstract] [Full Text] [Related]
20. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Zhao MH.
BMC Med; 2014 May 20; 12():81. PubMed ID: 24884842
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
